Document is current
Any future updates will be listed below
-
Authors
Li, Edmond
Lounsbury, Olivia
Clarke, Jonathan
Ashrafian, Hutan
Darzi, Ara
Neves, Ana Luisa
-
Funding
Funding for this research was provided by:
Patient Safety Translational Research Centre (PSTRC-2016-004)
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 26 November 2024
First Online: 3 December 2024
Declarations
:
: Overall ethical approval for this study was granted by the Imperial College Research Ethics Committee (ICREC) (Reference No. 22IC7425). This is a dedicated ethics oversight body at Imperial College London for all health-related research involving human participants. All participants provided written informed consent prior to participating in the study and consented to their focus group sessions being recorded.
: All participants provided written informed consent for anonymised quotes from their focus groups to be used in the publication of this study.
: HA is the chief scientific officer of Pre-emptive Health and Medicine at Flagship Pioneering. AD is the executive chair of Pre-emptive Health and Medicine at Flagship Pioneering. All other authors do not have any competing interests.
